EFTA01157239Set 9
2015-06-3033p14,596w
Miami 2012, 13-20 Dec 2012, Fort Lauderdale
Florida.
• Invited participant and talk: Hamiltonian Formulation of Open Super(Strings), Branes, Super-
gravity and M- Theory A conference to celebrate ... implicit and explicit solutions are constructed and analyzed in some detail.
The (super) twistor formulation, in D=3 and 4, and 6 space-time dimensions, of the dynamics
of various ... massless and massive spinning particles and superparticles, was developed and reviewed.
In this formulation the (super)twistor variables are alternatives to the usual phase-space and do
not append
https://www.justice.gov/epstein/files/DataSet%209/EFTA01157239.pdf
EFTA00614975Set 9
2015-06-3033p14,601w
Miami 2012, 13-20 Dec 2012, Fort Lauderdale
Florida.
• Invited participant and talk: Hamiltonian Formulation of Open Super(Strings), Branes, Super-
gravity and M- Theory A conference to celebrate ... implicit and explicit solutions are constructed and analyzed in some detail.
The (super) twistor formulation, in D=3 and 4, and 6 space-time dimensions, of the dynamics
of various ... massless and massive spinning particles and superparticles, was developed and reviewed.
In this formulation the (super)twistor variables are alternatives to the usual phase-space and do
not append
https://www.justice.gov/epstein/files/DataSet%209/EFTA00614975.pdf
EFTA00059325Set 9
2019-08-0146p16,322w
these thoughts.
Clinical knoresslon
According to his last Diagnostic and Care Level Formulation Note dated 7/09/19 by Dr. Miller, "No Diagnosis, No Dx -
Current?
Fk linos
The determination of whether ... EFTA00059351
Bureau of Prisons **SENSITIVE BUT UNCLASSIFIED"
Psychology Services
Diagnostic and Care Level Formulation
Inmate Name: EPSTEIN, JEFFREY EDWARD Reg tr: 76318-054
Date of Birth: 01/20/1953 Sex: M Facility ... assessment in order to determine whether he is currently at-risk for suicidality.
Diagnostic Formulation
Inmate Epstein has no history of mental health problems and does not exhibit suicidality
https://www.justice.gov/epstein/files/DataSet%209/EFTA00059325.pdf
EFTA00797069Set 9
2017-12-28186p61,016w
Cannabis Science 101 15
The Cannabis Plant • The Human Endocannabinoid System
Cannabinoids ■ Terpenes • Cannabis Formulations
CHAPTER III Cannabis Industry Segmentation 31
2 Production u Distribution • Consumer Products
• Business Solutions • Digital ... submitted a New Drug Application (NDA) to the FDA for Epidio-
lex, an oral formulation of cannabis-derived cannabidiol, or CBD, intended to treat severe forms of
childhood epilepsy ... Camphene • Daryophyllene Humulene Limonene
Linalool r Myrcene Pinene • Terpinolene
■ Cannabis Formulations
The"Entourage Effect"
The cannabis industry is currently focused on identifying and producing customized formulations of
cannabinoids and terpenes
https://www.justice.gov/epstein/files/DataSet%209/EFTA00797069.pdf
EFTA01114598Set 9
12p10,178w
measurement can be done only with a single par-
of spacetime from dynamics formulated in momentum space.
ticle and it defines, as we will see, a metric on momentum ... modified version of spacetime geometry
is emergent from the dynamics which is formulated on mo- D(p) a &(p,0) = m2. (2)
mentum space. In these sections we consider ... primary, they themselves need momenta, so that a
canonical dynamics can be formulated. The momenta of the = gak(O)Le (23)
momenta are quantities xi that live in the cotangent
https://www.justice.gov/epstein/files/DataSet%209/EFTA01114598.pdf
EFTA01113381Set 9
8p2,027w
delivery systems 11,346 13,388 15,798 44,503 23.0
Drug development and formulation 9,345 10,563 12,571 32,266 20.7
Diagnostic imaging, diagnostic testing ... level represents a large loss of time and money to the developing
company.
Drug formulation is also a critical step along the pathway from drug discovery to
commercialization. Nanoparticle drug ... clinical trials and eventual production. For many drugs, the task of finding the
right formulation to allow the drug to be delivered to the cell target in the proper amount
https://www.justice.gov/epstein/files/DataSet%209/EFTA01113381.pdf
EFTA01130416Set 9
2013-07-02220p48,786w
information contained within those
7 materials include principles that I relied upon in
8 formulating my opinions in this case, I think would be a
9 more accurate ... asking me.
24 If you are asking whether I had any involvement in
25 formulating the law, the answer to that question is I
OUELLETTE & MA LDIN COURRT REPORTERS ... Page 20
1 did not.
2 Q. Who did? To your knowledge, who did formulate
3 the law?
4 A. The Florida Legislature.
5 Q. Do you have any idea
https://www.justice.gov/epstein/files/DataSet%209/EFTA01130416.pdf
EFTA00598642Set 9
230p95,432w
China in order to develop new
and more precise solutions, such as special formulations,
that meet local customers specific needs.
In addition to the familiar hair needs, new consumer ... Japan. Evonik is already working with leading manufac-
turers on the development of formulations that can offer
the right solution for each type of packaging. That's be-
cause regardless ... them. Especially in the case of active ingredients with now make it possible to formulate parenteral depot
EFTA00598677
medications that can be injected directly beneath the skin
or into
https://www.justice.gov/epstein/files/DataSet%209/EFTA00598642.pdf
EFTA01130196Set 9
2013-07-02220p48,765w
information contained within those
7 materials include principles that I relied upon in
8 formulating my opinions in this case, I think would be a
9 more accurate ... asking me.
24 If you are asking whether I had any involvement in
25 formulating the law, the answer to that question is I
OUELLETTE & MAUI DIN COURT REPORTERS ... Page 20
1 did not.
2 Q. Who did? To your knowledge, who did formulate
3 the law?
4 A. The Florida Legislature.
5 Q. Do you have any idea
https://www.justice.gov/epstein/files/DataSet%209/EFTA01130196.pdf